High-sensitivity C-reactive protein (hs-CRP) and tumor necrotizing factor-alpha (TNF-alpha) after on- and off- pump

H Javadzadegan1, N Nezami, K Ghobadi

  • 1Department of Cardiology, Tabriz University (Medical Sciences), Tabriz, Iran.

Insights

Coronary artery bypass grafting (CABG) surgery increases high-sensitivity C-reactive protein (hs-CRP) levels. However, this study found no significant differences in hs-CRP or tumor necrosis factor-alpha between on-pump and off-pump CABG procedures.

Area of Science:

  • Cardiovascular Surgery
  • Inflammatory Biomarkers
  • Cardiac Surgery Outcomes

Background:

  • Coronary artery bypass grafting (CABG) is a common surgical procedure worldwide.
  • Inflammatory markers like hs-CRP and TNF-alpha are implicated in cardiac surgery.
  • Comparing on-pump versus off-pump CABG is crucial for optimizing patient outcomes.

Purpose of the Study:

  • To investigate the differences in hs-CRP and TNF-alpha levels between on-pump and off-pump CABG.
  • To assess the impact of surgical technique on systemic inflammation post-CABG.

Main Methods:

  • Prospective study involving 90 patients undergoing CABG.
  • Measurement of hs-CRP and TNF-alpha using ELISA kits.
  • Comparison of biomarker levels between on-pump and off-pump surgical groups.

Main Results:

  • hs-CRP levels significantly increased after CABG (p<0.001).
  • No significant differences in hs-CRP levels were observed between on-pump and off-pump groups (p=0.4).
  • No significant differences in TNF-alpha levels were observed between on-pump and off-pump groups (p=0.8).

Conclusions:

  • Surgical approach (on-pump vs. off-pump) does not appear to influence post-CABG hs-CRP or TNF-alpha levels.
  • Both surgical techniques result in comparable inflammatory responses based on these biomarkers.
  • Further research may explore other inflammatory mediators or long-term outcomes.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...